DNM1L and cancer: Cancer cells, in general, are known for their alterations in RNA splicing and processing (Ciesla et al, 2021; Song et al, 2019; Tien et al, 2017), and it remains to be determined if specific alterations in the RNA splicing machinery give rise to higher expression of Drp1(-/17).